FDA Adverse Event Injury Summary report: N

SYNCHROMED

MDR report key: 1650632 · Received April 1, 2010

Report

Report Number
3007566237-2010-02648
Event Type
Injury
Date Received
April 1, 2010
Date of Event
February 14, 2010
Report Date
March 16, 2010
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4).

Description of Event or Problem · 1

LITERATURE: MUNTS AG, VOORMOLEN JH, MARINUS J, DELHAAS EM, VAN HILTEN JJ. POSTDURAL PUNCTURE HEADACHE IN COMPLEX REGIONAL PAIN SYNDROME: A RETROSPECTIVE OBSERVATIONAL STUDY. PAIN MED. NOV 2009;10(8):1469-1475. SUMMARY: THIS ARTICLE DESCRIBES THE UNUSUAL COURSE OF POSTDURAL HEADACHE (PDPH) AFTER PUMP IMPLANTATION FOR INTRATHECAL BACLOFEN (ITB) ADMINISTRATION IN PATIENTS WITH COMPLEX REGIONAL PAIN SYNDROME (CRPS)-RELATED DYSTONIA. THE INFORMATION IS CASE SERIES BASED ON DATA COLLECTED FROM 1996 TO 2005 ON A TOTAL OF 54 PATIENTS WITH CRPS-RELATED DYSTONIA WHO WERE TREATED WITH ITB. REPORTABLE EVENT: FOURTEEN PATIENTS WITH PDPH, WITHOUT CSF LEAK, DID NOT RECEIVE AN EPIDURAL BLOOD PATCH (EBP). IT WAS ALSO NOTED, SIX PATIENTS WITH PDPH BUT WITHOUT CSF LEAK RECEIVED IV KETAMINE. PDPH RESOLVED IN FOUR OF THESE PATIENTS DURING 2 - 10 DAYS OF TREATMENT. IT WAS FURTHER NOTED, FOURTEEN OF FIFTEEN PATIENTS WHO EXPERIENCED EXACERBATION OF THEIR CRPS ALSO HAD PDPH WITHOUT CSF LEAK. (IT WAS NOT IDENTIFIED FURTHER WHICH OF THE 14 PATIENTS RECEIVED TREATMENTS OF IV KETAMINE, OR EXPERIENCED EXACERBATION OF THEIR CRPS).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SYNCHROMED LKK MEDTRONIC NEUROMODULATION PUMP NA

Patients

Seq Age Sex Outcome Treatment
1 IMPLANTED:| CATHETER: MODEL UNK, SERIAL # UNK| EXPLANTED: